Dependence of time to reach steady-state on the length of dosage interval

Annals of Pharmacotherapy

Volumn 42, Issue 10, 2008, Pages 1518-1519

  Mehvar, Reza ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; DIGOXIN; VANCOMYCIN;

BOLUS INJECTION; CONCENTRATION RESPONSE; DOSE RESPONSE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; LETTER; PRIORITY JOURNAL; STEADY STATE;

DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; HUMANS; INFUSIONS, INTRAVENOUS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; TIME FACTORS;

EID: 52949089066     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L251     Document Type: Letter

References (5)

1. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker, 1982:123-4.
2. Rowland M, Tozer TN. Clinical pharmacokinetics: concepts and applications. 3rd ed. Philadelphia: Williams &Wilkins, 1995:103.
3. Dhillon S, Kostrzewski A. Clinical pharmacokinetics. Chicago: Pharmaceutical Press, 2006:14.
4. Toutain PL, Bousquet-Melou A. Plasma terminal half-life. J Vet Pharmacol Ther 2004;27:427-39.
5. D'Angio RG, Gwilt PR. Time to steady state following a change in dosing rate. DICP 1989;23:468-72.